Biochemics sec

Author: ubkc

August undefined, 2024

WebAug 29, 2024 · According to the complaint, when BioChemics finally did conduct one clinical trial, it misrepresented the results of that trial. The complaint further alleged that Masiz … WebBiochemists work in industries like agriculture, medical research, biotechnology and nutritional research. Our students go on to positions in research and industry, as well as graduate study in biochemistry, …

BioChemics Claims It Can Pay Chunk Of $17M SEC Judgment

Webthe SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December 2012 (after the expiration of the policy period). Biochemics notified AXIS of the January and March 2012 subpoenas. WebDeveloper of transdermal drug delivery technology designed to offer treatment for the skin. new chesterfield

Biochemics, Inc. v. Axis Reinsurance Co.: When Does a D&O …

WebJan 14, 2014 · Biochemics, Inc. Overview. Biochemics, Inc. filed as a Foreign For-Profit Corporation in the State of Texas on Tuesday, January 14, 2014 and is approximately nine years old, as recorded in documents filed with Texas Secretary of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state … WebDec 16, 2012 · The SEC claims that in 2010 and 2011 BioChemics, Masiz, and Kroning misrepresented to investors and potential investors the status of research collaborations with other pharmaceutical companies: “For example, in 2010 and 2011, BioChemics published a multiple-page overview entitled Executive Summary (“Executive Summary”) that touted … WebJan 6, 2015 · Plaintiffs BioChemics, Inc., and John Masiz sued defendant Axis Reinsurance Company (“AXIS”) for defense costs arising out of a Securities and Exchange Commission (“SEC”) investigation and enforcement action under their directors and officers (“D & O”) liability insurance policy. internet archive the robe

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF …

BioChemics Inc - Company Profile and News - Bloomberg Markets

WebAug 7, 2013 · BioChemics is a specialty pharmaceutical company focused on transdermal drug delivery systems, including medicated lotions. Masiz is BioChemics's president and chief executive officer. In May 2011 and September 2011, the SEC served document subpoenas on BioChemics requesting a broad range of documents regarding the … WebLaw360, Boston (October 10, 2024, 5:10 PM EDT) -- After dodging a $17 million payment to the U.S. Securities and Exchange Commission, BioChemics Inc. will have to deal with a court-appointed... new chester fire dept grand marshWeb•the SEC served deposition subpoenas on Masiz and two other individuals in January 2012 (during the policy period); • the SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and • the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December … newchester football

"WebLaw360 (May 11, 2024, 9:54 PM EDT) -- Axis Reinsurance Co. on Thursday urged the First Circuit to uphold a Massachusetts federal judge's ruling that it doesn't have to cover BioChemics Inc.'s... " - Biochemics sec

Biochemics sec

WebSep 6, 2024 · In Biochemics, Inc. v. AXIS Reinsurance Company, 2024 WL 2223125 (1st Cir. 2024), the SEC issued a subpoena to Biochemics on May 5, 2011, requesting that Biochemics produce certain documentation in connection with the SEC’s investigation into whether Biochemics and its President and CEO, John Masiz, had committed securities … WebDec 14, 2012 · SEC Charges Massachusetts Company, CEO and Promoters With $9 Million Securities Fraud Recently, the Securities and Exchange Commission filed an enforcement action in federal court in Boston against BioChemics, Inc., a biopharmaceutical company based in Danvers, Massachusetts, its CEO and two individuals it paid to solicit investors.

Did you know?

Webbiochemistry: [noun] chemistry that deals with the chemical compounds and processes occurring in organisms. WebMar 25, 2015 · The judgment entered on March 25, 2015, supplements the March 18, 2015 judgment, and requires BioChemics to disgorge $15,105,325 in ill-gotten gains plus …

WebCompany profile page for BioChemics Inc including stock price, company news, press releases, executives, board members, and contact information WebThe treatment that could produce the money for BioChemics to pay down its SEC debt is already being prescribed by doctors associated with “leading medical institutions,” Schlichtmann said. In addition to the $17.2 million BioChemics owes the SEC, Florida-based private equity firm ADEC Private

WebGet free access to the complete judgment in Sec. & Exch. Comm'n v. BioChemics, Inc. on CaseMine. WebBiochemistry or biological chemistry is the study of chemical processes within and relating to living organisms. A sub-discipline of both chemistry and biology, biochemistry may be divided into three fields: structural …

WebDefine biochemics. biochemics synonyms, biochemics pronunciation, biochemics translation, English dictionary definition of biochemics. ... The SEC previously obtained a $17 million judgment against BioChemics and a separate judgment against a promoter of BioChemics stock who wasn't registered as a broker.

WebLaw360, Boston (September 11, 2024, 6:30 PM EDT) -- The U.S. Securities and Exchange Commission and a Massachusetts federal judge appeared skeptical Tuesday of BioChemics Inc.'s claims that it... internet archive the holidayWebThe SEC claimed in a 2012 lawsuit that BioChemics and Masiz lied about the status of topical gels that would allow medicine to be absorbed through the skin. They allegedly falsely asserted the... new chester mpWebJan 17, 2024 · See SEC v. BioChemics, Inc. et al., No. 12-12324-MLW (D. Mass.). On 8/18/18 the Commission dismissed the claims against Masiz under Section 10 (b) of, and … internet archive the sims 2WebJun 24, 2024 · In BioChemics, Inc. v. AXIS Reinsurance Co., 2024 WL 2223125 (1st Cir. May 23, 2024), the United States Court of Appeals for the First Circuit held that a D&O policy did not provide coverage for an SEC … internet archive the price is rightWebDec 14, 2012 · BioChemics of Danvers faces fraud charges By Beth Healy Globe Staff,December 14, 2012, 2:17 p.m. Federal securities regulators on Friday filed civil fraud charges against BioChemics Inc. of... internet archive the room 2003WebAug 22, 2024 · According to the SEC complaint, BioChemics, Masiz and co-conspirators were accused of engaging in a fraudulent scheme to sell company securities to approximately 70 investors. The scheme, which ran from 2009 until the middle of 2012, netted at least $9 million. Investors caught up in the scheme resided in 19 different states. internet archive the thingWebDec 17, 2012 · Courthouse News Staff / December 17, 2012. BOSTON (CN) - An attorney duped investors for $9 million through his purported biopharma company, Biochemics, … new chester manager